Streetbeat News

Price Targets

SNCY

Goldman Sachs analyst Catherine O'Brien has maintained a Neutral rating on Sun Country Airlines (NASDAQ:SNCY) and lowered the price target from $20 to $17.

Portfolio Pulse from Benzinga Newsdesk

August 17, 2023 | 12:19 pm

LUV

Goldman Sachs analyst Catherine O'Brien has maintained a Neutral rating on Southwest Airlines (NYSE:LUV) and lowered the price target from $34 to $30.

Portfolio Pulse from Benzinga Newsdesk

August 17, 2023 | 12:19 pm

HA

Goldman Sachs analyst Catherine O'Brien has maintained a 'Sell' rating on Hawaiian Holdings (NASDAQ:HA) and lowered the price target from $9 to $8.

Portfolio Pulse from Benzinga Newsdesk

August 17, 2023 | 12:17 pm

HRB

Goldman Sachs analyst George Kelly maintains a Sell rating on H&R Block (NYSE:HRB) and raises the price target from $28 to $32.

Portfolio Pulse from Benzinga Newsdesk

August 17, 2023 | 12:16 pm

DLO

Goldman Sachs analyst Tito Labarta maintains a Buy rating on DLocal (NASDAQ:DLO) and raises the price target from $21 to $24.

Portfolio Pulse from Benzinga Newsdesk

August 17, 2023 | 12:15 pm

TGT

Target Corporation reported Q2 FY23 sales of $24.77 billion, a 4.9% YoY decline, missing analyst consensus of $25.18 billion. Adjusted EPS of $1.80 beat the consensus of $1.39. However, Target lowered its FY23 adjusted EPS guidance from $7.75-$8.75 to $7.00-$8.00 and expects a mid-single-digit decline in comparable sales. Following the earnings announcement, Goldman Sachs, B of A Securities, and BMO Capital all lowered their price targets on Target.

Portfolio Pulse from Lisa Levin

August 17, 2023 | 12:14 pm

BRX

Goldman Sachs analyst Caitlin Burrows maintains a Buy rating on Brixmor Property Group (NYSE:BRX) and raises the price target from $23 to $27.

Portfolio Pulse from Benzinga Newsdesk

August 17, 2023 | 12:13 pm

AAL

Goldman Sachs analyst Catherine O'Brien has maintained a Neutral rating on American Airlines Group (NASDAQ:AAL) and lowered the price target from $17 to $15.

Portfolio Pulse from Benzinga Newsdesk

August 17, 2023 | 12:12 pm

IOVA

JMP Securities analyst Reni Benjamin has reiterated a Market Outperform rating on Iovance Biotherapeutics (NASDAQ:IOVA) and maintained a price target of $18.

Portfolio Pulse from richadhand@benzinga.com

August 17, 2023 | 12:11 pm

GPMT

JMP Securities analyst Steven Delaney has reiterated a Market Outperform rating on Granite Point Mortgage (NYSE:GPMT) and maintained a $9 price target.

Portfolio Pulse from richadhand@benzinga.com

August 17, 2023 | 12:10 pm